DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 208437
NDA 208437 describes LONHALA MAGNAIR KIT, which is a drug marketed by Sunovion Resp and is included in one NDA. It is available from one supplier. There are nine patents protecting this drug. Additional details are available on the LONHALA MAGNAIR KIT profile page.
The generic ingredient in LONHALA MAGNAIR KIT is glycopyrrolate. There are seventeen drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the glycopyrrolate profile page.
The generic ingredient in LONHALA MAGNAIR KIT is glycopyrrolate. There are seventeen drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the glycopyrrolate profile page.
Summary for 208437
| Tradename: | LONHALA MAGNAIR KIT |
| Applicant: | Sunovion Resp |
| Ingredient: | glycopyrrolate |
| Patents: | 9 |
| Formulation / Manufacturing: | see details |
Pharmacology for NDA: 208437
| Mechanism of Action | Cholinergic Antagonists |
Medical Subject Heading (MeSH) Categories for 208437
Suppliers and Packaging for NDA: 208437
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| LONHALA MAGNAIR KIT | glycopyrrolate | SOLUTION;INHALATION | 208437 | NDA | Sunovion Pharmaceuticals Inc. | 63402-201 | 63402-201-00 | 1 CARTON in 1 KIT (63402-201-00) > 30 POUCH in 1 CARTON > 2 VIAL, SINGLE-DOSE in 1 POUCH > 1 mL in 1 VIAL, SINGLE-DOSE |
| LONHALA MAGNAIR KIT | glycopyrrolate | SOLUTION;INHALATION | 208437 | NDA | Sunovion Pharmaceuticals Inc. | 63402-301 | 63402-301-01 | 1 CARTON in 1 KIT (63402-301-01) > 30 POUCH in 1 CARTON > 2 VIAL, SINGLE-DOSE in 1 POUCH > 1 mL in 1 VIAL, SINGLE-DOSE |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INHALATION | Strength | 25MCG/ML | ||||
| Approval Date: | Dec 5, 2017 | TE: | RLD: | Yes | |||||
| Regulatory Exclusivity Expiration: | Dec 5, 2020 | ||||||||
| Regulatory Exclusivity Use: | NEW PRODUCT | ||||||||
| Patent: | ➤ Try a Free Trial | Patent Expiration: | Oct 27, 2020 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
| Patent: | ➤ Try a Free Trial | Patent Expiration: | Sep 6, 2022 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
Complete Access Available with Subscription
